Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIXNASDAQ:BBLGNASDAQ:GCTKNASDAQ:NAYA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.24+3.3%$1.74$1.14▼$42.40$3.34M-3.46337,443 shs101,889 shsBBLGBone Biologics$5.91+11.5%$4.63$3.42▼$25.50$2.89M0.75236,026 shs83,376 shsGCTKGlucoTrack$6.32+1.4%$8.71$5.16▼$3,756.00$2.98M-0.1944,892 shs150,611 shsNAYANAYA Biosciences$1.26+0.8%$1.81$1.38▼$17.04$839K2.0353,151 shs103,557 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical+3.33%-4.62%-30.57%-37.69%-94.46%BBLGBone Biologics+12.57%+24.82%+8.06%+11.93%-33.89%GCTKGlucoTrack+1.44%+10.99%-24.76%-64.71%-99.77%NAYANAYA Biosciences0.00%-13.70%-42.20%-54.01%+125,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.375 of 5 stars3.52.00.00.01.11.71.3BBLGBone Biologics1.0091 of 5 stars0.05.00.00.01.20.01.3GCTKGlucoTrack0.639 of 5 stars0.05.00.00.01.40.80.0NAYANAYA BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.501,230.65% UpsideBBLGBone Biologics 0.00N/AN/AN/AGCTKGlucoTrack 0.00N/AN/AN/ANAYANAYA Biosciences 3.00Buy$24.001,804.76% UpsideCurrent Analyst Ratings BreakdownLatest NAYA, AMIX, GCTK, and BBLG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025AMIXAutonomix MedicalMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$3.29 per shareN/ABBLGBone BiologicsN/AN/AN/AN/A$8.39 per shareN/AGCTKGlucoTrackN/AN/AN/AN/A($983.35) per shareN/ANAYANAYA Biosciences$6.23M0.13N/AN/A($2.06) per share-0.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$11.41M-$7.47N/AN/AN/AN/A-174.70%-133.35%N/ABBLGBone Biologics-$4.11MN/A0.00N/AN/AN/A-130.21%-119.39%8/8/2025 (Estimated)GCTKGlucoTrack-$22.60M-$56.60N/A∞N/AN/AN/A-544.87%N/ANAYANAYA Biosciences-$8.03MN/A0.00∞N/A-119.91%N/A-41.72%6/29/2025 (Estimated)Latest NAYA, AMIX, GCTK, and BBLG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/29/2025Q4 2025AMIXAutonomix MedicalN/A-$0.74N/A-$0.74N/AN/A5/14/2025Q1 2025GCTKGlucoTrackN/A-$20.40N/A-$0.67N/AN/A5/12/2025Q1 2025BBLGBone Biologics-$2.88-$1.92+$0.96-$0.32N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ABBLGBone BiologicsN/AN/AN/AN/AN/AGCTKGlucoTrackN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A5.635.63BBLGBone BiologicsN/A12.6012.60GCTKGlucoTrack0.034.854.85NAYANAYA BiosciencesN/A0.230.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%BBLGBone Biologics34.30%GCTKGlucoTrack10.92%NAYANAYA Biosciences12.02%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%BBLGBone Biologics6.10%GCTKGlucoTrack12.91%NAYANAYA Biosciences1.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical12.78 million1.88 millionN/ABBLGBone Biologics2550,000512,000Not OptionableGCTKGlucoTrack5480,000416,000Not OptionableNAYANAYA Biosciences10666,0004.40 millionN/ANAYA, AMIX, GCTK, and BBLG HeadlinesRecent News About These CompaniesComparing Stryker (NYSE:SYK) & NAYA Biosciences (NASDAQ:NAYA)June 20 at 3:27 AM | americanbankingnews.comINVO Fertility, Inc.: INVO Fertility Confirms New Nasdaq Trading Symbol of "IVF"April 29, 2025 | finanznachrichten.deINVO Fertility Inc.April 29, 2025 | barrons.comINVO Fertility announces new Nasdaq trading symbolApril 25, 2025 | markets.businessinsider.comMaxim Group downgrades NAYA Biosciences (NAYA) to a HoldApril 25, 2025 | markets.businessinsider.comINVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”April 24, 2025 | globenewswire.comNAYA Biosciences IncApril 18, 2025 | morningstar.comNAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”April 14, 2025 | globenewswire.comNAYA BIOSCIENCES Earnings Preview: Recent $NAYA Insider Trading, Hedge Fund Activity, and MoreApril 14, 2025 | nasdaq.comNAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025March 13, 2025 | globenewswire.comNAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility TreatmentFebruary 25, 2025 | globenewswire.comNAYA Biosciences Announces Nomination of New Board MembersFebruary 19, 2025 | globenewswire.comNAYA Stock Hits 52-Week Low at $0.35 Amid Market ChallengesFebruary 12, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNAYA, AMIX, GCTK, and BBLG Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.24 +0.04 (+3.33%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.23 -0.01 (-0.81%) As of 06/20/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Bone Biologics NASDAQ:BBLG$5.91 +0.61 (+11.51%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$5.86 -0.05 (-0.93%) As of 06/20/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.GlucoTrack NASDAQ:GCTK$6.32 +0.09 (+1.44%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$6.42 +0.09 (+1.50%) As of 06/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.NAYA Biosciences NASDAQ:NAYA$1.26 +0.01 (+0.80%) As of 06/18/2025NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
